Ovintiv (OVV) said late Monday it secured regulatory approvals from the Toronto Stock Exchange to renew its normal course issuer bid to buy back almost 22.3 million common shares over the 12-month period starting Oct. 3.
The company also renewed its automatic share purchase plan to buy shares under the issuer bid when it would not be allowed to purchase shares due to regulatory limits and blackout periods, according to the company.
Ovintiv repurchased over 7.8 million common shares at an average price of $38.8 apiece out of the 25.9 million under its existing issuer bid, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.